SYNOVIAL SARCOMA
Clinical trials for SYNOVIAL SARCOMA explained in plain language.
Never miss a new study
Get alerted when new SYNOVIAL SARCOMA trials appear
Sign up with your email to follow new studies for SYNOVIAL SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Custom-Made vaccine fights rare childhood cancers
⭐️ VACCINE ⭐️ Recruiting nowThis study is testing a personalized peptide vaccine for children and young adults (up to age 30) with metastatic fusion-driven sarcomas (Ewing sarcoma, rhabdomyosarcoma, synovial sarcoma) who have completed standard treatment. The vaccine is custom-made for each patient based on…
Matched conditions: SYNOVIAL SARCOMA
Phase: PHASE1, PHASE2 • Sponsor: University Hospital Tuebingen • Aim: ⭐️ VACCINE ⭐️
Last updated May 17, 2026 01:48 UTC
-
New stem cell combo aims to fight stubborn childhood cancers
Disease control Recruiting nowThis study tests a stem cell transplant that removes certain immune cells (alpha/beta T cells and CD19+ B cells) and adds a drug called zoledronic acid. The goal is to help the donor cells attack the tumor without causing severe side effects. It is for children and young adults a…
Matched conditions: SYNOVIAL SARCOMA
Phase: PHASE1, PHASE2 • Sponsor: University of Florida • Aim: Disease control
Last updated May 17, 2026 01:51 UTC
-
New combo therapy targets tough cancers in early trial
Disease control Recruiting nowThis early-stage trial tests a new treatment combining two experimental therapies (IMA203 and mRNA-4203) for people with advanced melanoma or synovial sarcoma that has spread or can't be removed. The main goal is to check safety and find the best dose. About 15 participants will …
Matched conditions: SYNOVIAL SARCOMA
Phase: PHASE1 • Sponsor: Immatics US, Inc. • Aim: Disease control
Last updated May 17, 2026 01:49 UTC
-
Experimental cancer vaccine combo targets tough tumors in early trial
Disease control Recruiting nowThis early-phase study tests a new treatment called PeptiCRAd-1, a virus-based cancer vaccine, combined with the immunotherapy drug pembrolizumab. The goal is to see if this combination is safe and can boost the immune system to fight several types of solid tumors, including mela…
Matched conditions: SYNOVIAL SARCOMA
Phase: PHASE1 • Sponsor: Valo Therapeutics Oy • Aim: Disease control
Last updated May 17, 2026 01:49 UTC
-
Last-Resort access: experimental cell therapy offered to sarcoma patients
Disease control AVAILABLEThis program gives patients with synovial sarcoma or myxoid liposarcoma access to a cell therapy called TECELRA® when their prescribed batch doesn't meet quality standards. It's for people who cannot get a new batch made or undergo another cell collection. The goal is to provide …
Matched conditions: SYNOVIAL SARCOMA
Sponsor: USWM CT, LLC • Aim: Disease control
Last updated May 17, 2026 01:48 UTC
-
Engineered immune cells join forces with checkpoint drugs to fight hard-to-treat sarcomas
Disease control Recruiting nowThis early-phase study tests whether giving specially engineered immune cells (HER2-CAR T cells) together with an immune checkpoint inhibitor (pembrolizumab or nivolumab) is safe and can help people with advanced sarcoma. About 25 participants will receive chemotherapy to prepare…
Matched conditions: SYNOVIAL SARCOMA
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 17, 2026 01:47 UTC
-
Engineered immune cells take on rare sarcomas in early trial
Disease control Recruiting nowThis early-phase trial tests a new treatment for people with advanced synovial sarcoma or myxoid/round cell liposarcoma. Participants receive donated immune cells (NK cells) that are specially designed to recognize and attack cancer, along with chemotherapy to prepare the body. T…
Matched conditions: SYNOVIAL SARCOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Experimental drug aims to revive failing cancer fighters in rare sarcomas
Disease control Recruiting nowThis early study tests a drug called N-803 in 8 people with rare soft-tissue sarcomas (synovial sarcoma or myxoid/round cell liposarcoma) whose cancer grew after a prior cell therapy. N-803 is an immune-boosting protein that may help the body's remaining cancer-fighting cells wor…
Matched conditions: SYNOVIAL SARCOMA
Phase: EARLY_PHASE1 • Sponsor: Northwestern University • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
New hope for rare sarcoma: phase 3 drug trial now recruiting
Disease control Recruiting nowThis study tests a drug called AL3818 (anlotinib) for people with a rare cancer called alveolar soft part sarcoma that has spread or cannot be removed by surgery. The goal is to see if the drug can shrink tumors or slow cancer growth. Participants take AL3818 pills daily, and the…
Matched conditions: SYNOVIAL SARCOMA
Phase: PHASE3 • Sponsor: Advenchen Laboratories, LLC • Aim: Disease control
Last updated May 13, 2026 16:04 UTC
-
Personalized cell therapy trial opens for kids with rare tumors
Disease control Recruiting nowThis study tests a new treatment called afamitresgene autoleucel in children and young adults aged 2 to 21 with advanced cancers like synovial sarcoma, neuroblastoma, and osteosarcoma. The treatment uses the patient's own immune cells, modified to target a protein called MAGE-A4 …
Matched conditions: SYNOVIAL SARCOMA
Phase: PHASE1, PHASE2 • Sponsor: USWM CT, LLC • Aim: Disease control
Last updated May 11, 2026 20:41 UTC